Physical Activity in Adolescents With Familial Mediterranean Fever
Key facts
- Who runs it
- Istanbul University - Cerrahpasa
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 172 people, planned
- Started
- 15 May 2025
- Planned end
- 15 Nov 2025
- Type of study
- Observational, 2 groups
- Record updated
- 16 May 2025
Who can take part
- Age
- 12 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Be between 12-18 years of age
- Have been diagnosed with FMF for at least 6 months at the Pediatric Rheumatology Department of Istanbul Faculty of Medicine
- Be undergoing routine medical treatment for FMF
- Be willing to participate in the study
- Be between 12-18 years of age
- Be willing to participate in the study
Who cannot take part
- Presence of scoliosis, leg length discrepancy, or recent lower extremity surgery
- Presence of scoliosis, leg length discrepancy, or recent lower extremity surgery
- Adolescents whose participation in the study is not wanted by their family
- Having vestibular or neurological balance problems
- Adolescents with visual or hearing impairments
- Adolescents whose participation in the study is not wanted by their family
- Having vestibular or neurological balance problems
- Adolescents with visual or hearing impairments
- Leaving at least 3 questions unanswered in the questionnaires
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 18 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Familial Mediterranean Fever (FMF) is one of the most common autoinflammatory rheumatic diseases in childhood. Problems such as joint pain, muscle weakness, decreased aerobic capacity, and fatigue seen in children and adolescents with rheumatic disease may lead to low physical fitness levels. Limitation of physical performance is one of the possible consequences of chronic diseases that occur during childhood. At the same time, children with chronic illness face many challenges in participating in physical activity. Pediatric patients with rheumatic diseases tend to be physically inactive and, compared to their healthy peers, generally avoid participating in physical activity due to the limitations imposed by the disease. Often, the disease itself paves the way for decreased functional capacity and the development of deconditioning. Therefore, prescribing physical activity and exercise to pediatric populations with chronic illnesses is of great importance. This approach helps alleviate both the symptoms related to chronic diseases and the lifelong complications secondary to pharmacological treatments, and also prevents the development of new chronic conditions.
Read full original descriptionShow less
Participation in adequate physical activity is one of the most important behaviors individuals can adopt to maintain their health and well-being. Globally, public health physical activity guidelines address the exercise needs of children and adolescents. The European Alliance of Associations for Rheumatology (EULAR) highlights in its physical activity and exercise guidelines for patients with rheumatic diseases that the physical activity recommendations made for the general population are also applicable to patients with rheumatic diseases.
With this cohort study, it is aimed to examine physical activity (PA) in detail in adolescents diagnosed with FMF and to compare them with healthy peers. This study is one of the first in our country to provide comprehensive data on the PA levels of adolescents with FMF. The findings obtained will contribute to understanding PA levels and exercise perception, and guide the planning of exercise programs to be developed for these individuals. Moreover, the results of the study may also serve as a basis for future research in children and adolescents with various chronic diseases, especially those with FMF.
The 2 groups in the trial
- Familial Mediterranean Fever
The study will include 76 patients diagnosed with Familial Mediterranean Fever who are being followed at the Division of Pediatric Rheumatology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University.
- Healthy control
The study will include healthy peers of adolescents diagnosed with FMF.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigation of Physical Activity in Adolescents Diagnosed With Familial Mediterranean Fever
- Criteria questions
- Built from NCT06974942, who can take part
- Record updated
- 16 May 2025